Latin America

Retail sales of digestive remedies saw accelerated growth in constant value terms in 2023, as consumers returned to their busy, pre-pandemic lifestyles. With fears over the COVID-19 pandemic beginning to subside, there was notable increase in the…

For the second consecutive year, dietary supplements is expected to register a significant fall in volume sales. Two main factors are causing this negative performance. With concerns about COVID-19 abating, consumers are less concerned about boosting…

Dietary supplements is enjoying healthy growth, with trends similar to those seen in vitamins. For example, products which offer multiple benefits are proving popular and, in this case, combination dietary supplements is showing the most robust…

Following the emergence of the pandemic in 2020 and into the following year, dietary supplements experienced robust growth, fuelled by consumers' desire to boost their immune systems and overall health. However, consumer interests shifted during…

Towards the end of the review period, direct seller Herbalife launched a new product called Immunity Essentials. This supplement can be mixed into water, tea or other drinks, and is taken once a day to support the functioning of the immune system. It…

Probiotic supplements is a standout product within dietary supplements and is expected to register double-digit volume growth in 2023. Probiotics supplements are available over the counter, but part of their success is due to sales representatives…

Dietary supplements continues to expand in 2023 as consumers have a large variety of products to choose from and are responding favourably to new product launches. At the end of 2022, for instance, Megalabs, launched InvitaEnergy, a combination of…

Omega-3 supplements have gained immense popularity in Costa Rica due to the growing awareness among people about their health benefits. Omega-3 fatty acids are considered essential nutrients that cannot be produced by the body, and are therefore…

The dietary supplements category is expected to experience positive growth rates in 2023, largely driven by prices, although the growth is expected to be slower than that seen previously in the review period. Despite the increasing concern amongst…

Dietary supplements in Chile is experiencing a resurgence in dynamic value growth in 2023, following a decline the previous year. This renewed growth can be attributed to the growing interest among consumers in educating themselves about the…

Dietary supplements is expected to see solid current value growth in Brazil in 2023, maintaining the trend seen for many years. During the years of the pandemic, consumers predominantly focused on products that strengthened their immune system. While…

While dietary supplements are expected to register moderate current value growth, constant value growth is expected to be minimal. Dietary supplements are mainly imported and in 2023 costs have been rising for imports, due to a sharp decline in…

Despite ongoing economic instability, consumers remained keen to maintain healthy lifestyles in order to help boost their immune systems. This, alongside the expansion of health food shops, boosted retail volume sales of dietary supplements in 2023.…

Dermatologicals is expected to register moderate constant value and volume growth in 2023. Dermatologicals continues to recover from the removal of pandemic restrictions. With patients again visiting doctors for the last two years, this is a…

Dermatologicals, in some regards, are driven by environmental factors. As such, the emergence of the El Niño Costero climatological event, which increased temperatures in Peru, especially along the coast, ultimately resulted in a higher number of…

While sales of dermatologicals continue to grow in 2023, reflecting a recovery from pandemic-related disruptions. demand is stabilising. Mexicans are no longer facing increased risks to their skin compared to the previous year, and some…

Top topical antifungals brands such as Canesten (Bayer), Lamisil (Haleon), and Unesia (Genomma) keep this segment competitive as each continues vying for more market share. Consumer demand for these products is expected to remain strong over the…

Medicated shampoo is expected to register the highest current value growth in dermatologicals in 2023, with the big winner being Genommalab’s Medicasp. This brand has significantly increased value share over the review period. With substantial…

Despite the challenging economic conditions affecting the country, consumers continue to purchase a variety of dermatological products as awareness about treating certain conditions increases. Categories such as haemorrhoid treatments, medicated…

As consumers face stress due to economic uncertainty and skin imbalances after COVID-19, many suffer from hair loss, helping category growth. While some consumers opt for dietary supplements to avoid hair loss, others turn to shampoos or other…

Dermatologicals is expected to see higher value growth in 2023 than in the previous year. Value growth is partly being driven by escalating prices and partly by people returning to in-person medical consultations, which lead to more recommendations…

Dermatologicals maintain a healthy growth trajectory in line with figures recorded in 2022, retaining significant value sales that surpass pre-pandemic levels. While this category typically demonstrates notable stability and does not exhibit…

Dermatologicals is set to maintain a healthy growth trajectory in current value terms in Brazil in 2023, in line with the increase recorded in 2022, driven mainly by price rises. The pandemic years were marked by a reduction in Brazilians’ purchasing…

With society operating normally once again, after the pandemic, visits to doctors in relation to skin conditions have increased. This is seeing products such as topical antifungals, vaginal antifungals, cold sore treatments, and haemorrhoid…

Retail sales of dermatologicals saw a second year of healthy growth in constant value terms in 2023. The category suffered a decline during the pandemic, when consumers spent more time at home and were therefore less exposed to environments which…

With value sales of cough and cold and allergy ( hay fever) remedies reducing to more normal levels. as concern about COVID-19 abate, there is expected to be a decline in volume sales in 2023. The exception being medicated confectionery. Along with…

Consumers have been returning to doctors’ surgeries in the post-pandemic landscape, thus hindering the sales of OTC medicines which they are instead accessing via prescription. This is noted to be the case with antihistamines, for example, along with…

In early 2023, a sixth wave of COVID-19 coincided with an upsurge in cases of the common cold and influenza, creating a "tripledemic" felt across Mexico, the US, and Central American countries, with Mexico experiencing a milder impact. This scenario…

Cough, cold and allergy (hay fever) remedies are widely consumed consumer health items in the Guatemalan market. These products have established broad distribution throughout the country, with products available throughout the modern and traditional…

Cough, cold and allergy (hay fever) remedies are expected to register a decline in value sales. Value sales are now at more normal levels, as concerns about the COVID-19 virus have abated. In addition, Ecuador is grappling with rising crime rates and…

Cough, cold and allergy (hay fever) remedies are among the most popular consumer health items in the Dominican Republic and are experiencing further growth in 2023 despite higher unit prices resulting largely from persistent inflationary pressures…

At the end of 2022, there was an increase in the need to treat cold and flu symptoms. This was driven by the return of socialising following periods of social distancing, increased hand washing and the wearing of face masks throughout most of 2020…

In 2022, demand for cold, cough and allergy (have fever) remedies soared, as a result of the atypical increase in flu cases, as social distancing, handwashing protocols, and the use of face masks were totally lifted in 2022, facilitating the spread…

Cough, cold, and allergy (hay fever) remedies in Chile is experiencing remarkable growth for the second consecutive year in 2023, both in terms of volume and value. This upward trend can be attributed primarily to the return to normalcy following the…

In 2023, cough, cold and allergy (hay fever) remedies is set to maintain dynamic current value growth in Brazil. In this year, the conclusion of the Public Health Emergency of International Concern (PHEIC) for COVID-19, as declared by the World…

Seasonal flus have returned, as people mix together once again , post pandemic, and cough, cold and allergy (hay fever remedies) are expected to register moderate current value growth, though constant value growth will be minimal, as rising costs hit…

Retail sales of cough, cold and allergy (hay fever) remedies saw another year of healthy growth in constant value terms in 2023. With the resumption of pre-pandemic lifestyles, including a return to work, school and social activities, consumers…

The picture is fairly positive in 2023, with constant value sales expected to rise slightly and inflationary pressure easing. However, rising prices are still an issue and the overall economy is expected to register a slowdown in growth.

Consumer health shows variable recovery in 2023, with an ongoing return to the normalisation of sales patterns following the atypical period of the pandemic. Challenges, however, continue, such as the departure of President Castillo's government, in…

Consumer health declined in volume sales while retail value sales grew below inflation in 2023. This was mainly due to significant falls in the vitamins and dietary supplements and weight management and wellbeing categories while sports nutrition and…

Consumer health sales grew moderately in 2023 as consumers prioritised their spending on essential goods over preventive health. As a result, vitamins and dietary supplements and weight management and wellbeing were the most affected. However, sports…

In 2023, after three years of placing health at the forefront due to the pandemic, Mexicans have finally found some respite and are shifting their focus away from health concerns. While the public healthcare system grapples with supply shortages,…

Consumer health in Honduras experienced a year of growth in value terms in 2023 that was in line with the country's inflation. Categories such as analgesics, cough, cold and allergy (hay fever) remedies, dermatologicals, and sports nutrition…

Consumer health has seen demand dampened by consumers being confronted with very high inflation. The rate of 9.2% in 2022 was the highest experienced in decades. As a result, more consumers have been forced to prioritise household spending on…

Sales growth of consumer health in El Salvador in 2023 varied across categories. While OTC performed well, growing at above inflation, preventive health categories such as vitamins, dietary supplements and weight management recorded significant…

Ecuador is expected to register only a slight increase in current value sales in 2023. Ecuador is grappling with rising crime rates and political instability, with runoff elections scheduled in October. This is all leading to economic uncertainty and…

Despite persistent inflationary pressures in the country and wages that have not yet caught up with market conditions, consumer health recorded growth in 2023. Growth was supported by solid categories, including cough, cold and allergy (hay fever)…

In 2023, increased socialising and the return to post-pandemic habits support the growth of several OTC categories. However, high inflation and a fluctuating exchange rate continue to create uncertainty. Inflation in Costa Rica was 8.27% in 2022, the…

In 2023, Colombians returned to their familiar routines, with increasing social activity and hectic lifestyles leading to an increase in cases of cold and benefiting most OTC categories. However, the opposite trend is being observed in vitamins and…

Consumer health in Chile experienced a notable slowdown in value growth in 2022 compared to the previous year's performance. In 2021, the pandemic-induced liquidity in the local market and the shift towards preventive habits among consumers drove…